178 related articles for article (PubMed ID: 18286698)
1. KAI1 is a potential target for anti-metastasis in pancreatic cancer cells.
Xu JH; Guo XZ; Ren LN; Shao LC; Liu MP
World J Gastroenterol; 2008 Feb; 14(7):1126-32. PubMed ID: 18286698
[TBL] [Abstract][Full Text] [Related]
2. [The mechanism of KAI1 gene in inhibition of metastasis of primary pancreatic cancer].
Guo XZ; Xu JH; Liu MP; Ren LN; Wang D; Li HY; Wu CY
Zhonghua Nei Ke Za Zhi; 2004 May; 43(5):360-2. PubMed ID: 15182508
[TBL] [Abstract][Full Text] [Related]
3. KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models.
Yang JM; Peng ZH; Si SH; Liu WW; Luo YH; Ye ZY
Liver Int; 2008 Jan; 28(1):132-9. PubMed ID: 18028322
[TBL] [Abstract][Full Text] [Related]
4. KAI1 reverses the epithelial-mesenchymal transition in human pancreatic cancer cells.
Liu X; Guo XZ; Li HY; Chen J
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):471-477. PubMed ID: 30948327
[TBL] [Abstract][Full Text] [Related]
5. KAI1 inhibits lymphangiogenesis and lymphatic metastasis of pancreatic cancer in vivo.
Liu X; Guo XZ; Li HY; Chen J; Ren LN; Wu CY
Hepatobiliary Pancreat Dis Int; 2014 Feb; 13(1):87-92. PubMed ID: 24463085
[TBL] [Abstract][Full Text] [Related]
6. KAI1 inhibits HGF-induced invasion of pancreatic cancer by sphingosine kinase activity.
Liu X; Guo XZ; Zhang WW; Lu ZZ; Zhang QW; Duan HF; Wang LS
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):201-8. PubMed ID: 21459729
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD
Wang S; Chen J; Li H; Qi X; Liu X; Guo X
Technol Cancer Res Treat; 2021; 20():15330338211045204. PubMed ID: 34605330
[No Abstract] [Full Text] [Related]
8. KAI1 inhibits anchorage-dependent and -independent pancreatic cancer cell growth.
Guo XZ; Xu JH; Liu MP; Kleeff J; Ho CK; Ren LN; Li HY; Köninger J; Cui ZM; Wang D; Wu CY; Zhao JJ; Friess H
Oncol Rep; 2005 Jul; 14(1):59-63. PubMed ID: 15944768
[TBL] [Abstract][Full Text] [Related]
9. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells.
Takaoka A; Hinoda Y; Sato S; Itoh F; Adachi M; Hareyama M; Imai K
Jpn J Cancer Res; 1998 Apr; 89(4):397-404. PubMed ID: 9617345
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of KAI1 induces autophagy and increases MiaPaCa-2 cell survival through the phosphorylation of extracellular signal-regulated kinases.
Wu CY; Yan J; Yang YF; Xiao FJ; Li QF; Zhang QW; Wang LS; Guo XZ; Wang H
Biochem Biophys Res Commun; 2011 Jan; 404(3):802-8. PubMed ID: 21168384
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia and Serum deprivation protected MiaPaCa-2 cells from KAI1-induced proliferation inhibition through autophagy pathway activation in solid tumors.
Wu CY; Guo XZ; Li HY
Clin Transl Oncol; 2015 Mar; 17(3):201-8. PubMed ID: 25199507
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of KAI1 gene on breast cancer cell growth in vitro].
Lu D; Wang WX; Xu YQ; Jiang QY; Yang Y
Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):580-3. PubMed ID: 18210875
[TBL] [Abstract][Full Text] [Related]
13. Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases.
Friess H; Guo XZ; Berberat P; Graber HU; Zimmermann A; Korc M; Büchler MW
Int J Cancer; 1998 Aug; 79(4):349-55. PubMed ID: 9699525
[TBL] [Abstract][Full Text] [Related]
14. Effects of KAI gene expression on ferroptosis in pancreatic cancer cells.
Liu X; Guo X; Li H; Chen J; Han H
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33655331
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells.
Yang X; Wei LL; Tang C; Slack R; Mueller S; Lippman ME
Cancer Res; 2001 Jul; 61(13):5284-8. PubMed ID: 11431371
[TBL] [Abstract][Full Text] [Related]
16. Suppression of invasive properties of colon cancer cells by a metastasis suppressor KAI1 gene.
Takaoka A; Hinoda Y; Satoh S; Adachi Y; Itoh F; Adachi M; Imai K
Oncogene; 1998 Mar; 16(11):1443-53. PubMed ID: 9525743
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.
Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA
Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362
[TBL] [Abstract][Full Text] [Related]
18. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
Liu CJ; Yang JH; Huang FZ; Yang JH; Liu CP; Mao XH; Yi WM; Shen XB; Peng C; Chen MF; Jiang B; Wu JS
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2273-2281. PubMed ID: 29762829
[TBL] [Abstract][Full Text] [Related]
19. Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaB.
Melisi D; Niu J; Chang Z; Xia Q; Peng B; Ishiyama S; Evans DB; Chiao PJ
Mol Cancer Res; 2009 May; 7(5):624-33. PubMed ID: 19435817
[TBL] [Abstract][Full Text] [Related]
20. KAI1/CD82 Genetically Engineered Endothelial Progenitor Cells Inhibit Metastasis of Human Nasopharyngeal Carcinoma in a Mouse Model.
Wang G; Zhang L; Zhou Y; Sun Q; Xu H; Cai F; Xiang P; Chen Z; Jiang H
Med Sci Monit; 2018 May; 24():3146-3152. PubMed ID: 29755107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]